Daclatasvir (dihydrochloride) [CAS 1009119-65-6]
Partner: MedChemexpress LLC
| CAS No: | 1009119-65-6 |
| Applications: | COVID-19-anti-virus |
| MW: | 811.80 |
| Formula: | C40H52Cl2N8O6 |
| SMILES: | O=C(N1CCC[C@H]1C2=NC=C(C3=CC=C(C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C([C@H](C(C)C)NC(OC)=O)=O)C=C3)N2)[C@H](C(C)C)NC(OC)=O.[H]Cl.[H]Cl |
| Purity: | 99.68 |
| Description: | Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 �M and 3.27 �M, respectively[1][2][3]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
